Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- DIAGNOSTIC NEWS IN BRIEF
December 10, 2001
- 9 NCEs Including Glivec, Rebetol Listed
December 10, 2001
- MEDICAL DEVICE NEWS IN BRIEF
December 10, 2001
- Bayer Medical: Smear Sampling, Staining Device ADVIA S60
December 3, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -3-
December 3, 2001
- Bayer Medical: Myocardial Infarction Marker Kit
December 3, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -2-
December 3, 2001
- Shionogi Ties Up with SRL in Lab Test Business
December 3, 2001
- Banyu: Nu-lotan Boosts Sales, but Profits Down due to Loss Caused by Securities Sale
December 3, 2001
- Korosho Requires Inspections of Hollow-fiber Dialyzers
December 3, 2001
- CORPORATE ROUNDUP NEWS IN BRIEF -1-
December 3, 2001
- GEYMS: Top of the Line LOGIQ Ultrasound Device Introduced
December 3, 2001
- Listed Wholesalers' Profits Plummet Despite Increases in Sales
December 3, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
December 3, 2001
- BUSINESS NEWS IN BRIEF
December 3, 2001
- WORLD NEWS IN BRIEF
December 3, 2001
- Aiming at \2 Trillion Sales in FY2009: Kuraya Sanseido President
December 3, 2001
- RESEARCH AND DEVELOPMENT NEWS IN BRIEF
December 3, 2001
- Kissei Withdraws Additional Indication Application for Rizaben
December 3, 2001
- Nippon Roche, GSK/IPF Hold Seminars on Influenza
December 3, 2001
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…